List of Chapters/Sections(Table Of Content)
1 Conjugate Vaccine Market Overview
1.1 Product Overview and Scope of Conjugate Vaccine
1.2 Conjugate Vaccine Segment by Type
1.2.1 Global Conjugate Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Hib Vaccine
1.2.3 Meningococcal Vaccine
1.2.4 Pneumococcal Vaccine
1.2.5 Others
1.3 Conjugate Vaccine Segment by End Users
1.3.1 Global Conjugate Vaccine Sales Comparison by End Users: (2021-2027)
1.3.2 Children
1.3.3 Adult
1.4 Global Conjugate Vaccine Market Size Estimates and Forecasts
1.4.1 Global Conjugate Vaccine Revenue 2016-2027
1.4.2 Global Conjugate Vaccine Sales 2016-2027
1.4.3 Conjugate Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Conjugate Vaccine Market Competition by Manufacturers
2.1 Global Conjugate Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Conjugate Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Conjugate Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Conjugate Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Conjugate Vaccine Market Competitive Situation and Trends
2.5.1 Conjugate Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Conjugate Vaccine Players Market Share by Revenue
2.5.3 Global Conjugate Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Conjugate Vaccine Retrospective Market Scenario by Region
3.1 Global Conjugate Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Conjugate Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Conjugate Vaccine Market Facts & Figures by Country
3.3.1 North America Conjugate Vaccine Sales by Country
3.3.2 North America Conjugate Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Conjugate Vaccine Market Facts & Figures by Country
3.4.1 Europe Conjugate Vaccine Sales by Country
3.4.2 Europe Conjugate Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Conjugate Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Conjugate Vaccine Sales by Region
3.5.2 Asia Pacific Conjugate Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Conjugate Vaccine Market Facts & Figures by Country
3.6.1 Latin America Conjugate Vaccine Sales by Country
3.6.2 Latin America Conjugate Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Conjugate Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Conjugate Vaccine Sales by Country
3.7.2 Middle East and Africa Conjugate Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Conjugate Vaccine Historic Market Analysis by Type
4.1 Global Conjugate Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Conjugate Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Conjugate Vaccine Price by Type (2016-2021)
5 Global Conjugate Vaccine Historic Market Analysis by End Users
5.1 Global Conjugate Vaccine Sales Market Share by End Users (2016-2021)
5.2 Global Conjugate Vaccine Revenue Market Share by End Users (2016-2021)
5.3 Global Conjugate Vaccine Price by End Users (2016-2021)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Conjugate Vaccine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GSK Conjugate Vaccine Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Sanofi Conjugate Vaccine Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Merck Conjugate Vaccine Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 Walvax Biotechnology
6.5.1 Walvax Biotechnology Corporation Information
6.5.2 Walvax Biotechnology Description and Business Overview
6.5.3 Walvax Biotechnology Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Walvax Biotechnology Conjugate Vaccine Product Portfolio
6.5.5 Walvax Biotechnology Recent Developments/Updates
6.6 Royal (Wuxi) Bio-Pharmaceutical
6.6.1 Royal (Wuxi) Bio-Pharmaceutical Corporation Information
6.6.2 Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
6.6.3 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Royal (Wuxi) Bio-Pharmaceutical Conjugate Vaccine Product Portfolio
6.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
6.7 Bharat Biotech
6.6.1 Bharat Biotech Corporation Information
6.6.2 Bharat Biotech Description and Business Overview
6.6.3 Bharat Biotech Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bharat Biotech Conjugate Vaccine Product Portfolio
6.7.5 Bharat Biotech Recent Developments/Updates
6.8 Zhifei Biologic
6.8.1 Zhifei Biologic Corporation Information
6.8.2 Zhifei Biologic Description and Business Overview
6.8.3 Zhifei Biologic Conjugate Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Zhifei Biologic Conjugate Vaccine Product Portfolio
6.8.5 Zhifei Biologic Recent Developments/Updates
7 Conjugate Vaccine Manufacturing Cost Analysis
7.1 Conjugate Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Conjugate Vaccine
7.4 Conjugate Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Conjugate Vaccine Distributors List
8.3 Conjugate Vaccine Customers
9 Conjugate Vaccine Market Dynamics
9.1 Conjugate Vaccine Industry Trends
9.2 Conjugate Vaccine Growth Drivers
9.3 Conjugate Vaccine Market Challenges
9.4 Conjugate Vaccine Market Restraints
10 Global Market Forecast
10.1 Conjugate Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Conjugate Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Conjugate Vaccine by Type (2022-2027)
10.2 Conjugate Vaccine Market Estimates and Projections by End Users
10.2.1 Global Forecasted Sales of Conjugate Vaccine by End Users (2022-2027)
10.2.2 Global Forecasted Revenue of Conjugate Vaccine by End Users (2022-2027)
10.3 Conjugate Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Conjugate Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Conjugate Vaccine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
